Vitiligo is an acquired pigmentary disorder of the skin and mucous membranes that is characterized by circumscribed, depigmented macules and patches. The condition is frequently associated with disorders of autoimmune origin, with thyroid abnormalities. . . .
Vitiligo is an acquired condition where there is patchy loss of melanin from the epidermis, causing areas of pale skin. There may also be loss of melanin in hair follicles. It is usually seen as an autoimmune disease and is associated with other such. . . .
Many Dermatologists Are Perhaps Not Aware That From Time To Time A Large Variety Of Drugs Have Been Used For The Treatment Of Vitiligo. This Book Contains A Comprehensive Review Of The Studies Undertaken To Evaluate These Drugs For Their Efficacy In. . . .
Although vitiligo has traditionally been very difficult to treat, a new breakthrough surgical treatment is expanding options for practitioners and patients.
Standard treatments depend on the severity of the condition and the patient's feelings. . . .
The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. This. . . .